Cellectis
CLLS
#9721
Rank
โ‚น9.88 B
Marketcap
โ‚น98.17
Share price
-4.17%
Change (1 day)
-66.18%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: โ‚น9.88 Billion

As of November 2026 Cellectis has a market cap of โ‚น9.88 Billion. This makes Cellectis the world's 9721th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น9.88 B-76.88%
2025โ‚น42.77 B246.68%
2024โ‚น12.33 B-32.77%
2023โ‚น18.35 B126.65%
2022โ‚น8.09 B-71.6%
2021โ‚น28.51 B-69.42%
2020โ‚น93.24 B75.32%
2019โ‚น53.18 B3.93%
2018โ‚น51.17 B-20.48%
2017โ‚น64.35 B56.41%
2016โ‚น41.14 B-42.34%
2015โ‚น71.36 B157.11%
2014โ‚น27.75 B570.96%
2013โ‚น4.13 B

End of Day market cap according to different sources

On Nov 2nd, 2026 the market cap of Cellectis was reported to be:

โ‚น9.91 Billion
by Nasdaq info icon info icon
โ‚น9.88 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚น9.431 T 95,278.65%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
โ‚น151.12 B 1,428.27%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
โ‚น149.09 B 1,407.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚น43.52 B 340.19%๐Ÿ‡บ๐Ÿ‡ธ USA